COMP <GO>
MGTX vs ODTX // EV/EBITDA & P/E VALUATION
MeiraGTx Holdings plc (NASDAQ) VS. Odyssey Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: MGTX 0
— ODTX 2
■ METRIC PARITY
LAST: $9.71 (-0.46%) • MKT CAP: $932.1M
valuation
—
LAST: $19.83 (+1.48%) • MKT CAP: $953.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MGTX VS. ODTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MGTX | ODTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.38% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 144.60% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.3 | 48.9 | -10.61 | ODTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $932.1M | $953.0M | -$20.9M | ODTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MGTX REV | ODTX REV | MGTX GROSS % | ODTX GROSS % | MGTX FCF | ODTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $81.4M | $0 | — | — | -$50.2M | — |
| FY 2024 | $33.3M | — | — | — | -$109.5M | — |
| FY 2023 | $14.0M | — | — | — | -$105.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MGTX // BETA —
ODTX // BETA —